The poliovirus receptor protein is produced both as membrane-bound and secreted forms.

PubWeight™: 3.31‹?› | Rank: Top 1%

🔗 View Article (PMC 552052)

Published in EMBO J on October 01, 1990

Authors

S Koike1, H Horie, I Ise, A Okitsu, M Yoshida, N Iizuka, K Takeuchi, T Takegami, A Nomoto

Author Affiliations

1: Department of Microbiology, Tokyo Metropolitan Institute of Medical Science, Japan.

Articles citing this

An analysis of vertebrate mRNA sequences: intimations of translational control. J Cell Biol (1991) 12.00

The ectodomain of a novel member of the immunoglobulin subfamily related to the poliovirus receptor has the attributes of a bona fide receptor for herpes simplex virus types 1 and 2 in human cells. J Virol (1998) 3.65

Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med (2003) 3.52

Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med (2009) 3.20

Transgenic mice susceptible to poliovirus. Proc Natl Acad Sci U S A (1991) 2.87

Molecular tectonic model of virus structural transitions: the putative cell entry states of poliovirus. J Virol (2000) 2.74

Interaction of the poliovirus receptor with poliovirus. Proc Natl Acad Sci U S A (2000) 2.42

The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J Virol (2005) 2.13

The first immunoglobulin-like domain of HveC is sufficient to bind herpes simplex virus gD with full affinity, while the third domain is involved in oligomerization of HveC. J Virol (1999) 2.03

Molecular cloning and expression of a murine homolog of the human poliovirus receptor gene. J Virol (1992) 1.94

Functional domains of the poliovirus receptor. Proc Natl Acad Sci U S A (1991) 1.77

A new cis-acting element for RNA replication within the 5' noncoding region of poliovirus type 1 RNA. J Virol (1995) 1.70

Poliovirus can enter and infect mammalian cells by way of an intercellular adhesion molecule 1 pathway. Proc Natl Acad Sci U S A (1991) 1.69

Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice. J Virol (1992) 1.65

Evidence for emergence of diverse polioviruses from C-cluster coxsackie A viruses and implications for global poliovirus eradication. Proc Natl Acad Sci U S A (2007) 1.60

Interaction of poliovirus with its purified receptor and conformational alteration in the virion. J Virol (1998) 1.59

Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model. J Virol (2007) 1.54

Striking similarity of murine nectin-1alpha to human nectin-1alpha (HveC) in sequence and activity as a glycoprotein D receptor for alphaherpesvirus entry. J Virol (2000) 1.53

Biochemical characterization of rotavirus receptors in MA104 cells. J Virol (2000) 1.52

A mutation in VP4 defines a new step in the late stages of cell entry by poliovirus. J Virol (1993) 1.51

Crystal structure of CD155 and electron microscopic studies of its complexes with polioviruses. Proc Natl Acad Sci U S A (2008) 1.51

Transgenic mice carrying the human poliovirus receptor: new animal models for study of poliovirus neurovirulence. J Virol (1994) 1.44

Overexpression of the CD155 gene in human colorectal carcinoma. Gut (2001) 1.40

Complexes of poliovirus serotypes with their common cellular receptor, CD155. J Virol (2003) 1.31

Structural features of nectin-2 (HveB) required for herpes simplex virus entry. J Virol (2001) 1.30

Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses. J Virol (1995) 1.26

Mouse neurovirulence determinants of poliovirus type 1 strain LS-a map to the coding regions of capsid protein VP1 and proteinase 2Apro. J Virol (1994) 1.25

Receptor (CD155)-dependent endocytosis of poliovirus and retrograde axonal transport of the endosome. J Virol (2004) 1.20

Direct interaction between two viral proteins, the nonstructural protein 2C and the capsid protein VP3, is required for enterovirus morphogenesis. PLoS Pathog (2010) 1.20

Selective isolation of poliovirus in recombinant murine cell line expressing the human poliovirus receptor gene. J Clin Microbiol (1994) 1.16

Host range phenotype induced by mutations in the internal ribosomal entry site of poliovirus RNA. J Virol (1997) 1.15

Substitutions in the capsids of poliovirus mutants selected in human neuroblastoma cells confer on the Mahoney type 1 strain a phenotype neurovirulent in mice. J Virol (1994) 1.14

Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. J Virol (2013) 1.14

Mouse adaptation determinants of poliovirus type 1 enhance viral uncoating. J Virol (1996) 1.11

A second gene for the African green monkey poliovirus receptor that has no putative N-glycosylation site in the functional N-terminal immunoglobulin-like domain. J Virol (1992) 1.11

A seamless trespass: germ cell migration across the seminiferous epithelium during spermatogenesis. J Cell Biol (2007) 1.10

Interaction of poliovirus with its receptor affords a high level of infectivity to the virion in poliovirus infections mediated by the Fc receptor. J Virol (1999) 1.09

Cell-dependent role for the poliovirus 3' noncoding region in positive-strand RNA synthesis. J Virol (2004) 1.07

Poliovirus receptor (CD155) regulates a step in transendothelial migration between PECAM and CD99. Am J Pathol (2013) 1.05

Bidirectional entry of poliovirus into polarized epithelial cells. J Virol (1993) 1.04

Mutational analysis of the cellular receptor for poliovirus. J Virol (1991) 1.04

Nectin like-5 overexpression correlates with the malignant phenotype in cutaneous melanoma. Oncotarget (2012) 1.02

Inhibition of cell movement and proliferation by cell-cell contact-induced interaction of Necl-5 with nectin-3. J Cell Biol (2005) 1.02

Early phosphatidylinositol 3-kinase/Akt pathway activation limits poliovirus-induced JNK-mediated cell death. J Virol (2008) 0.99

Role of the alpha/beta interferon response in the acquisition of susceptibility to poliovirus by kidney cells in culture. J Virol (2006) 0.99

Novel, soluble isoform of the herpes simplex virus (HSV) receptor nectin1 (or PRR1-HIgR-HveC) modulates positively and negatively susceptibility to HSV infection. J Virol (2001) 0.99

Tissue-specific replicating capacity of a chimeric poliovirus that carries the internal ribosome entry site of hepatitis C virus in a new mouse model transgenic for the human poliovirus receptor. J Virol (2003) 0.97

Neutrophil and monocyte recruitment by PECAM, CD99, and other molecules via the LBRC. Semin Immunopathol (2013) 0.97

The herpes simplex virus JMP mutant enters receptor-negative J cells through a novel pathway independent of the known receptors nectin1, HveA, and nectin2. J Virol (2004) 0.97

A double-selective tissue culture system for isolation of wild-type poliovirus from sewage applied in a long-term environmental surveillance. Appl Environ Microbiol (1999) 0.97

Temperature-sensitive mouse cell factors for strand-specific initiation of poliovirus RNA synthesis. J Virol (1993) 0.96

Innate host barriers to viral trafficking and population diversity: lessons learned from poliovirus. Adv Virus Res (2010) 0.96

Receptor-dependent and -independent axonal retrograde transport of poliovirus in motor neurons. J Virol (2009) 0.96

Poliovirus-induced apoptosis is reduced in cells expressing a mutant CD155 selected during persistent poliovirus infection in neuroblastoma cells. J Virol (2003) 0.92

Strategies for the identification of icosahedral virus receptors. J Clin Invest (1992) 0.91

Poliovirus induces Bax-dependent cell death mediated by c-Jun NH2-terminal kinase. J Virol (2007) 0.89

Cooperative role of nectin-nectin and nectin-afadin interactions in formation of nectin-based cell-cell adhesion. J Biol Chem (2011) 0.88

Development of a particle agglutination method with soluble virus receptor for identification of poliovirus. J Clin Microbiol (2010) 0.88

A new internal ribosomal entry site 5' boundary is required for poliovirus translation initiation in a mouse system. J Virol (1998) 0.87

Correlation between poliovirus type 1 Mahoney replication in blood cells and neurovirulence. J Virol (1996) 0.86

N glycosylation of the virus binding domain is not essential for function of the human poliovirus receptor. J Virol (1992) 0.85

A host-specific, temperature-sensitive translation defect determines the attenuation phenotype of a human rhinovirus/poliovirus chimera, PV1(RIPO). J Virol (2011) 0.83

Increased Soluble CD155 in the Serum of Cancer Patients. PLoS One (2016) 0.82

Persistent poliovirus infection in mouse motoneurons. J Virol (1997) 0.82

Kinetic models for receptor-catalyzed conversion of coxsackievirus B3 to A-particles. J Virol (2014) 0.80

Poliomyelitis in transgenic mice expressing CD155 under the control of the Tage4 promoter after oral and parenteral poliovirus inoculation. J Gen Virol (2014) 0.79

Isolation and molecular characterization of a poliovirus type 1 mutant that replicates in the spinal cords of mice. J Virol (1999) 0.79

Assay for identification of heterozygous single-nucleotide polymorphism (Ala67Thr) in human poliovirus receptor gene. Indian J Med Res (2016) 0.78

Reduced apoptosis in human intestinal cells cured of persistent poliovirus infection. J Virol (2006) 0.76

Molecular aspects of poliovirus pathogenesis. Proc Jpn Acad Ser B Phys Biol Sci (2007) 0.75

Molecular genetic analysis of revertants from a poliovirus mutant that is specifically adapted to the mouse spinal cord. J Virol (2001) 0.75

Characterization of the New World monkey homologues of human poliovirus receptor CD155. J Virol (2008) 0.75

The genetics of post-polio syndrome - much to be unravelled! Indian J Med Res (2016) 0.75

Particle agglutination method for poliovirus identification. J Vis Exp (2011) 0.75

Poliovirus Receptor: More than a simple viral receptor. Virus Res (2017) 0.75

CD155 expression and its correlation with clinicopathologic characteristics, angiogenesis, and prognosis in human cholangiocarcinoma. Onco Targets Ther (2017) 0.75

Articles cited by this

Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65

DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54

Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol (1977) 205.11

Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci U S A (1980) 109.70

Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc Natl Acad Sci U S A (1972) 83.88

A simple and very efficient method for generating cDNA libraries. Gene (1983) 55.36

Splicing of messenger RNA precursors. Annu Rev Biochem (1986) 14.41

The immunoglobulin superfamily--domains for cell surface recognition. Annu Rev Immunol (1988) 12.87

Two mRNAs can be produced from a single immunoglobulin mu gene by alternative RNA processing pathways. Cell (1980) 9.86

Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell (1989) 9.82

High-efficiency cloning of full-length cDNA; construction and screening of cDNA expression libraries for mammalian cells. Methods Enzymol (1987) 5.08

The mammalian cell-virus relationship. IV. Infection of naturally insusceptible cells with enterovirus ribonucleic acid. J Exp Med (1959) 3.84

Receptor affinities as major determinants of enterovirus tissue tropisms in humans. Virology (1961) 3.25

Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. J Virol (1989) 2.98

ACE1 regulates expression of the Saccharomyces cerevisiae metallothionein gene. Mol Cell Biol (1988) 2.81

Monoclonal antibodies which block cellular receptors of poliovirus. Virus Res (1984) 2.40

Pathogenesis of poliomyelitis; reappraisal in the light of new data. Science (1956) 2.37

Emerging concept of poliomyelitis infection. Science (1955) 2.26

Production of a monoclonal antibody against an epitope on HeLa cells that is the functional poliovirus binding site. J Gen Virol (1985) 2.08

Mechanism of entry into the cytosol of poliovirus type 1: requirement for low pH. J Cell Biol (1984) 2.05

Alternative splicing generates a secreted form of N-CAM in muscle and brain. Cell (1988) 1.97

Monoclonal antibody identification of a 100-kDa membrane protein in HeLa cells and human spinal cord involved in poliovirus attachment. Proc Natl Acad Sci U S A (1988) 1.73

Transformation of a human poliovirus receptor gene into mouse cells. Proc Natl Acad Sci U S A (1986) 1.68

Isolation of transforming DNA by cosmid rescue. Proc Natl Acad Sci U S A (1982) 1.38

The poliovirus sensitivity (PVS) gene is on chromosome 19q12----q13.2. Genomics (1988) 1.10

Regional location of a novel yes-related proto-oncogene, syn, on human chromosome 6 at band q21. Jpn J Cancer Res (1986) 0.89

Articles by these authors

A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc Natl Acad Sci U S A (2001) 33.71

CRM1 is an export receptor for leucine-rich nuclear export signals. Cell (1997) 18.60

Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci U S A (1983) 14.09

Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A (1982) 12.84

SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol Cell Biol (1988) 12.84

CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature (1997) 10.49

Direct observation of the rotation of F1-ATPase. Nature (1997) 9.57

Internal ribosome entry site within hepatitis C virus RNA. J Virol (1992) 9.14

Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants. J Mol Biol (1984) 8.06

A protein covalently linked to poliovirus genome RNA. Proc Natl Acad Sci U S A (1977) 7.92

The 5' end of poliovirus mRNA is not capped with m7G(5')ppp(5')Np. Proc Natl Acad Sci U S A (1976) 7.26

Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc Natl Acad Sci U S A (1999) 6.81

Laparoscopic cholecystectomy using fine-caliber instruments. Surg Endosc (1998) 6.62

Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp Cell Res (1998) 6.11

Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. Proc Natl Acad Sci U S A (1982) 6.09

Resolution of distinct rotational substeps by submillisecond kinetic analysis of F1-ATPase. Nature (2001) 5.63

The location of the polio genome protein in viral RNAs and its implication for RNA synthesis. Nature (1977) 5.61

Acute effects of passive smoking on the coronary circulation in healthy young adults. JAMA (2001) 5.43

Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci U S A (1984) 4.97

Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block. J Virol (1993) 4.76

O4-(5'-uridylyl)tyrosine is the bond between the genome-linked protein and the RNA of poliovirus. Proc Natl Acad Sci U S A (1978) 4.68

Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1. EMBO J (1986) 4.58

F1-ATPase is a highly efficient molecular motor that rotates with discrete 120 degree steps. Cell (1998) 4.47

Avian sarcoma virus Y73 genome sequence and structural similarity of its transforming gene product to that of Rous sarcoma virus. Nature (1982) 4.33

A cDNA fragment of hepatitis C virus isolated from an implicated donor of post-transfusion non-A, non-B hepatitis in Japan. Nucleic Acids Res (1989) 4.29

Leptomycin B targets a regulatory cascade of crm1, a fission yeast nuclear protein, involved in control of higher order chromosome structure and gene expression. J Biol Chem (1994) 4.28

Exploring the protein interactome using comprehensive two-hybrid projects. Trends Biotechnol (2001) 4.27

Functional activation of the long terminal repeat of human T-cell leukemia virus type I by a trans-acting factor. Proc Natl Acad Sci U S A (1985) 4.24

MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature (1999) 4.19

Transcriptional (p40x) and post-transcriptional (p27x-III) regulators are required for the expression and replication of human T-cell leukemia virus type I genes. Proc Natl Acad Sci U S A (1987) 4.10

Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1-encoded p40x and T3/Ti complex triggering. Cell (1987) 4.10

The 5'-terminal structures of poliovirion RNA and poliovirus mRNA differ only in the genome-linked protein VPg. Proc Natl Acad Sci U S A (1977) 3.97

Direct evidence that p40x of human T-cell leukemia virus type I is a trans-acting transcriptional activator. EMBO J (1986) 3.86

Construction of viable deletion and insertion mutants of the Sabin strain of type 1 poliovirus: function of the 5' noncoding sequence in viral replication. J Virol (1987) 3.79

A novel ES cell line, TT2, with high germline-differentiating potency. Anal Biochem (1993) 3.79

Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy. Science (1995) 3.66

Plasma (1-->3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet (1995) 3.64

Sequence of 3,687 nucleotides from the 3' end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins. Nucleic Acids Res (1983) 3.62

Membrane-dependent uridylylation of the genome-linked protein VPg of poliovirus. Proc Natl Acad Sci U S A (1983) 3.58

Characterization of Y73, an avian sarcoma virus: a unique transforming gene and its product, a phosphopolyprotein with protein kinase activity. Proc Natl Acad Sci U S A (1980) 3.58

Leucine zipper structure of the protein CRE-BP1 binding to the cyclic AMP response element in brain. EMBO J (1989) 3.56

A transcriptional enhancer sequence of HTLV-I is responsible for trans-activation mediated by p40 chi HTLV-I. EMBO J (1986) 3.53

Nectin/PRR: an immunoglobulin-like cell adhesion molecule recruited to cadherin-based adherens junctions through interaction with Afadin, a PDZ domain-containing protein. J Cell Biol (1999) 3.47

Post-transcriptional regulator (rex) of HTLV-1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins. EMBO J (1988) 3.45

Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem (1999) 3.34

p27x-III and p21x-III, proteins encoded by the pX sequence of human T-cell leukemia virus type I. Proc Natl Acad Sci U S A (1985) 3.34

Membrane fractions active in poliovirus RNA replication contain VPg precursor polypeptides. Virology (1983) 3.28

Initiation of poliovirus plus-strand RNA synthesis in a membrane complex of infected HeLa cells. J Virol (1986) 3.24

Characterisation of vaccine-derived polioviruses isolated from sewage and river water in Japan. Lancet (2000) 3.20

Human adult T-cell leukemia virus: molecular cloning of the provirus DNA and the unique terminal structure. Proc Natl Acad Sci U S A (1982) 3.19

Expression of the pX gene of HTLV-I: general splicing mechanism in the HTLV family. Science (1985) 3.18

GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity (2001) 3.13

Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation (2001) 3.03

Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. J Virol (1989) 2.98

Transgenic mice susceptible to poliovirus. Proc Natl Acad Sci U S A (1991) 2.87

Tyrosine phosphorylation of beta-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. Cell Adhes Commun (1994) 2.87

Wortmannin, a microbial product inhibitor of myosin light chain kinase. J Biol Chem (1992) 2.85

Regulation of yAP-1 nuclear localization in response to oxidative stress. EMBO J (1997) 2.84

Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor. Nucleic Acids Res (1994) 2.81

Nonspecific integration of the HTLV provirus genome into adult T-cell leukaemia cells. Nature (1984) 2.78

The virus of Japanese adult T-cell leukaemia is a member of the human T-cell leukaemia virus group. Nature (1982) 2.75

HIV/HTLV gene nomenclature. Nature (1988) 2.72

Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/.NO through a radical reaction. Biochemistry (1993) 2.70

A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB/IkappaBalpha complexes. Proc Natl Acad Sci U S A (2000) 2.64

Primary structure of poliovirus defective-interfering particle genomes and possible generation mechanisms of the particles. J Mol Biol (1986) 2.63

Cloned infectious complementary DNA of the poliovirus Sabin 1 genome: biochemical and biological properties of the recovered virus. Gene (1984) 2.55

Heat-inactivated proteins are rescued by the DnaK.J-GrpE set and ClpB chaperones. Proc Natl Acad Sci U S A (1999) 2.54

Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet (1995) 2.53

The trans-activator tax of human T-cell leukemia virus type 1 (HTLV-1) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-1. Proc Natl Acad Sci U S A (1993) 2.52

Unifected avian cells contain structurally unrelated progenitors of viral sarcoma genes. Nature (1980) 2.50

Complete nucleotide sequence of the genome of coxsackievirus B1. Virology (1987) 2.49

Complications and diagnosis of Meckel's diverticulum in 776 patients. Am J Surg (1992) 2.48

Multiple cDNA clones encoding nuclear proteins that bind to the tax-dependent enhancer of HTLV-1: all contain a leucine zipper structure and basic amino acid domain. EMBO J (1990) 2.44

Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase. J Biol Chem (1993) 2.40

Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line. Mol Cell Biol (1986) 2.33

Association of p120, a tyrosine kinase substrate, with E-cadherin/catenin complexes. J Cell Biol (1995) 2.32

Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc Natl Acad Sci U S A (2000) 2.32

Maintenance of G2 arrest in the Xenopus oocyte: a role for 14-3-3-mediated inhibition of Cdc25 nuclear import. EMBO J (1999) 2.29

In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain. J Virol (1985) 2.26

Two cis-acting elements responsible for posttranscriptional trans-regulation of gene expression of human T-cell leukemia virus type I. Proc Natl Acad Sci U S A (1988) 2.25

Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin. Proc Natl Acad Sci U S A (2001) 2.23

Active maintenance of mHDA2/mHDAC6 histone-deacetylase in the cytoplasm. Curr Biol (2000) 2.21

Recovery of pathogenic measles virus from cloned cDNA. J Virol (2000) 2.19

Construction of less neurovirulent polioviruses by introducing deletions into the 5' noncoding sequence of the genome. J Virol (1989) 2.19

Antigenic variation and resistance to neutralization in poliovirus type 1. Science (1985) 2.19

Identification of an essential glutamic acid residue in the beta subunit of the adenosine triphosphatase from the thermophilic bacterium PS3. J Biol Chem (1981) 2.19

A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes. Mol Cell Biol (1996) 2.18

Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut (2007) 2.15

Analysis of RNA synthesis of type 1 poliovirus by using an in vitro molecular genetic approach. J Virol (1987) 2.14

In vitro construction of poliovirus defective interfering particles. J Virol (1989) 2.10

T-cell activation signals and human T-cell leukemia virus type I-encoded p40x protein activate the mouse granulocyte-macrophage colony-stimulating factor gene through a common DNA element. Mol Cell Biol (1988) 2.08

Cell-free conversion of delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine into an antibiotic with the properties of isopenicillin N in Cephalosporium acremonium. Biochem J (1979) 2.08

Pause and rotation of F(1)-ATPase during catalysis. Proc Natl Acad Sci U S A (2001) 2.07

Poliovirus type 1/type 3 antigenic hybrid virus constructed in vitro elicits type 1 and type 3 neutralizing antibodies in rabbits and monkeys. Proc Natl Acad Sci U S A (1988) 2.07

In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I. Antimicrob Agents Chemother (1990) 2.05